Gedeon Richter PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GEDSF research report →
Companywww.gedeonrichter.com
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products.
- CEO
- Gabor Orban
- IPO
- 2000
- Employees
- 10,943
- HQ
- Budapest, HU
Price Chart
Valuation
- Market Cap
- $4.54B
- P/E
- 9.71
- P/S
- 2.42
- P/B
- 1.53
- EV/EBITDA
- 5.72
- Div Yield
- 3.54%
Profitability
- Gross Margin
- 67.55%
- Op Margin
- 33.69%
- Net Margin
- 24.80%
- ROE
- 16.73%
- ROIC
- 16.00%
Growth & Income
- Revenue
- $862.58B · 0.59%
- Net Income
- $215.73B · -9.83%
- EPS
- $1178.67 · -9.82%
- Op Income
- $300.59B
- FCF YoY
- 7.54%
Performance & Tape
- 52W High
- $24.85
- 52W Low
- $24.85
- 50D MA
- $24.85
- 200D MA
- $24.85
- Beta
- 0.33
- Avg Volume
- 240.752
Get TickerSpark's AI analysis on GEDSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GEDSF Coverage
We haven't published any research on GEDSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GEDSF Report →